Project description
RNA sequencing and AI for personalised obesity treatment
Obesity, a condition associated with severe diseases, poses a significant risk to human health. The EU-funded EXHEUSVITAL project proposes an evidence-based solution: assisting healthcare professionals to develop personalised treatment plans for individuals with obesity, with the goal of achieving effective weight management. The technology analyses an individual’s gene activation and generates insightful health reports. These reports not only provide information on the person’s current health status but also facilitate continuous patient monitoring. Furthermore, they offer a prognosis of potential pathologies and offer cost-effective therapy solutions. This comprehensive solution combines RNA sequencing and artificial intelligence (AI) technology to enhance recommendations. Additionally, it has the capability to track changes in activated genes over time.
Objective
Exheus VITAL is a unique, evidence-based innovative solution that supports HCPs in providing personalized treatment plans and recommendations to people suffering from obesity to effectively achieve weight management goals. The proprietary technology is based on individual’s gene activation analysis that is converted into insightful health intelligence reports which provide information on the health status of the individual, allow monitoring of patients’ over-time and a prognosis of possible pathologies. Exheus leads to unparalleled health outcomes, benefiting the individual and the society by driving cost-effectiveness of therapy.
Exheus VITAL offers advantages such as:
1.The information provided together by the RNA sequencing and by the Exheus AI technology allows to obtain precise information of the abnormalities in gene expression for each patient. This allow a high level of personalization that can’t be achieved with other methods to provide the best treatment for a given patient.
2.It allows to increase the adherence to the weight loss treatment increasing the effectiveness of the recommendations.
3.It helps HCPs motivate the patient and improve willingness to follow the health recommendations, therefore promoting a change in lifestyle habits sustainable over the time.
4.HCPs (i.e endocrinologist, primary care physicians) can now treat obesity through a clinically validated personalized medicine tool to guide and accompany the patient during its healthy weight loss process.
5.Monitoring the evolution of activated genes over time can be done through repeated tests to determine changes in these parameters.
Exheus VITAL is a fast, effective and attractive tool that helps Health Care Professionals (HCPs) to efficiently support patients with obesity in their weight loss goals. It has been demonstrated that the delivery of the scientifically proven insights (expression levels and changes) and recommendations using a digital method will be effective.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques.
- medical and health sciencesbasic medicinepathology
- natural sciencesbiological sciencesgeneticsRNA
- medical and health scienceshealth sciencesnutritionobesity
You need to log in or register to use this function
Keywords
Programme(s)
- HORIZON.3.2 - European innovation ecosystems Main Programme
Funding Scheme
HORIZON-CSA - HORIZON Coordination and Support ActionsCoordinator
08039 Barcelona
Spain
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.